theheart.org : Clinical cardiology

Clinical cardiology

Optimizing Outcomes in Ischemic Heart Disease Management: Issues and Answers

Jan 19, 2010 09:39 EST

Explore key issues in ischemic heart disease, including accurate diagnosis, risk stratification, and data involving new antianginal therapies.

Clinical cardiology

New Data and the Clinical Implications on the Use of High Loading and Maintenance Doses of Clopidogrel

4 COMMENTS - Oct 15, 2009 09:58 EDT

What effect does doubling the dose of clopidogrel have on outcomes in patients undergoing PCI? Dr. Salim Yusuf discusses the results of the CURRENT-OASIS 7 trial and other new data on antithrombotic agents.

Heart failure

Diagnosing and Treating Chest Discomfort of Cardiovascular Origin: The Role of Risk Stratification

3 COMMENTS - Oct 13, 2009 11:04 EDT

An older patient appearing obviously fatigued and "worn out" presents in the office complaining of heaviness in the chest, and shortness of breath especially with any type of exercise. Not your typical angina patient, or is it? How do you go about working up this patient to make the right diagnosis? Drs. Pepine and Wenger discuss the approach to patients with ischemia and treatment considerations.

Acute Coronary Syndromes

Meeting the Challenges in Long-Term Anticoagulation: Opportunities to Improve Patient Care

Aug 7, 2009 09:10 EDT

Management of long-term anticoagulation therapy in STEMI patients is challenging. Please join our expert panel, Drs. Elaine Hylek, Ander Cohen, Greg Lip, and Jack Ansell, as they discuss current challenges and strategies to optimize the benefit of and provide insights to the future of anticoagulation therapy.

Clinical cardiology

New Data on Polyvascular Disease and ACS

1 COMMENT - Jun 23, 2009 09:40 EDT

Recently published data suggest that prior polyvascular disease increases the risk for inhospital adverse events in patients with ACS. Join Drs. Deepak Bhatt, Jean-Pierre Bassand, and José R. Gonzalez-Juanatey for a discussion of the current data on identification and management of patients with polyvascular disease.

Clinical cardiology

Combination Therapy and Cardiovascular Events: A Neurologist's Perspective

1 COMMENT - Jun 17, 2009 11:48 EDT

AF can lead to stroke, congestive heart failure, and other serious complications. Successful management should include reducing these risks. Join our expert panel, Drs. Peter Rothwell, Donald Easton, and Mark Alberts, as they discuss new data and strategies for improving outcomes in patients with AF.

Clinical cardiology

2009 Antiplatelet Debate: What's New in ACS

7 COMMENTS - Jun 12, 2009 15:03 EDT

Despite modern therapy, the rates of death, MI, bleeding, and readmission remain high in patients with ACS. Join Drs. Jeffery Popma, Héctor Bueno, Freek Verheugt, and Sunil. Rao for a review of the latest data on antiplatelet therapy for patients with ACS.

Arrhythmia/EP

The Future of Ambulatory Monitoring: Moving Beyond Rate and Rhythm to Monitor ST-Segment Shifts

3 COMMENTS - May 29, 2009 12:00 EDT

How can we reduce the time taken to accurately diagnose ACS? ECGs and biomarkers may be nondiagnostic, even the presenting symptoms can vary or be absent. As every 30 minutes delay is associated with a 7.5% relative increase in mortality, time is indeed muscle. Join Drs. Gibson, Pride, Santini, and Krucoff as they present new insights into this complex field.

Clinical cardiology

Atherothrombosis and Bleeding Issues: Balancing Safety and Efficacy

May 14, 2009 08:34 EDT

Bleeding in ACS patients has been associated with increased adverse cardiac events and negative patient outcomes. Join Drs. Keith Fox, Gregg Stone, and Gabriel Steg as they discuss balancing the safety and efficacy of antithrombotic treatment options in ACS.

Clinical cardiology

Diagnosis and Treatment of Chronic Stable Angina: A Case Study for Clinical Practice

May 7, 2009 09:30 EDT

Dr Boden presents an interactive case study: Diagnosis and Treatment of Chronic Stable Angina.

Clinical cardiology

Preventing Vascular Events in AF: What Is the Role of Antiplatelet Therapy?

4 COMMENTS - Apr 28, 2009 10:00 EDT

Atrial fibrillation (AF) is the most frequently occurring cardiac arrhythmia affecting some 2.2 million Americans with often serious clinical consequences.. Join Drs. Bhatt, Connolly and Camm for a discussion on the risk factors, management challenges, and new data on treatment options for patients with AF

Clinical cardiology

Recent Advances in Pharmacologic Options for Treating Chronic Stable Angina

Feb 26, 2009 09:31 EST

Drs Scirica and Morrow present a review of pharmacologic management options in patients with stable ischemic heart disease.

Clinical cardiology

Update on combination antiplatelet therapy

Jul 31, 2007 09:30 EDT

This program discusses the optimal use of combination antiplatelet therapy in non-ST elevation ACS, both in the acute and long-term setting. Additionally, the program will touch upon the early use of combination antiplatelet therapy in the setting of STEMI. Referencing the recent joint statement on DES by the Canadian Association of Interventional Cardiologists and the Canadian Cardiovascular Society, the program will also discuss optimal duration of dual antiplatelet therapy, strategies to prevent early discontinuation, and potential management strategies for patients who may require surgery while on dual antiplatelet therapy.

Acute coronary syndromes

Antithrombotic therapy in STEMI: What happened at AHA 2006?

Nov 27, 2006 10:00 EST

What is the ideal antithrombotic therapy for the management of STEMI patients? Please join Dr Antman and an expert panel as they discuss the latest clinical trial data from the AHA 2006 Scientific Sessions regarding the management of STEMI patients.